BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	172,642.16 225.24M	-0.57% -993.92
ALLSHR	104,658.41 715.45M	-0.71% -746.89
KSE30	51,414.64 68.61M	-0.56% -288.52
KMI30	246,107.08 95.44M	-0.57% -1413.60
KMIALLSHR	67,826.46 385.67M	-0.56% -379.57
BKTi	48,132.23 23.42M	-0.63% -306.61
OGTi	35,082.07 7.07M	-0.26% -91.25

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	78,660.00	80,800.00 77,725.00	-1395.00 -1.74%
BRENT CRUDE	98.20	99.46 96.78	1.20 1.24%
RICHARDS BAY COAL MONTHLY	130.00	130.00 130.00	2.40 1.88%
ROTTERDAM COAL MONTHLY	140.00	0.00 0.00	2.25 1.63%
USD RBD PALM OLEIN	1,228.00	1,228.00 1,228.00	0.00 0.00%
CRUDE OIL - WTI	93.14	94.73 90.87	1.66 1.81%
SUGAR #11 WORLD	18.11	18.45 17.89	0.04 0.22%